PHASE II CLINICAL TRIAL OF SINOBIOMED’S MALARIA CANDIDATE VACCINE TO START IN Q3 | COMPANY COLLABORATING WITH MAHIDOL UNIVERSITY OF BANGKOK ON TRIAL TO BE CONDUCTED IN THAILAND
2008.01.08
SINOBIOMED SUBSIDIARY RECEIVES US$1.24 MILLION FUNDING TO ACCELERATE CLINICAL TRIAL & DEVELOPMENT OF MALARIA VACCINE - LARGEST EVER GOVERNMENT GRANT TO A CHINESE BIOPHARMACEUTICAL COMPANY
2007.11.29
SINOBIOMED UPDATES ON CLINCIAL TRIAL PROGRESS FOR MALARIA VACCINE, RBAT ETHEOPHAZINE AND RHK1
2007.10.18
CANADIAN SENATOR LARRY W. CAMPBELL JOINS SINOBIOMED INC. AS A DIRECTOR
2007.10.17
UPDATE ON SINOBIOMED’S ACQUISITION OF CHINESE PHARMACEUTICAL DISTRIBUTOR | SINOBIOMED BOOKS ACQUISITION’S REVENUE FOR SIX MONTHS ENDED JUNE 30, 2007 OF US$11.3 MILLION
2007.10.09
SINOBIOMED SUBSIDIARY GRANTED CHINESE PATENT FOR RECOMBINANT HEPATO REGENERATION FACTOR | PROTEIN STIMULATES GROWTH OF HUMAN LIVER CELLS; EXPECTED TO BE DRUG CANDIDATE FOR TREATMENT OF ACUTE LIVER FAILURE
2007.10.02
SINOBIOMED SUBSIDIARY NAMED "HIGH AND NEW TECHNOLOGY ENTERPRISE" | DESIGNATION GIVES FIRM 2 YEAR TAX EXEMPTION FOLLOWED BY 3 YEARS OF 50% TAX REDUCTION
2007.09.20
SINOBIOMED UPDATES ON COMPANY PROGRESS
2007.09.18
SINOBIOMED UPDATES ON CLINCIAL TRIAL SUCCESS FOR RECOMBINANT BATROXOBIN (rBat) | PHASE IIa CLINICAL TRIAL COMPLETE; rBat SHOWN TO HAVE SIGNIFICANT EFFECTS AS ANTI-BLEEDING AGENT COMPARED WITH CONTROL GROUP
2007.08.09
SINOBIOMED SIGNS DEFINITIVE AGREEMENT TO ACQUIRE CHINESE PHARMACEUTICAL DISTRIBUTOR | ACQUISITION OF SUZHOU BOAI GIVES SINOBIOMED CONTROL OF SFDA GSP CERTIFIED PHARMACEUTICAL DISTRIBUTOR THAT EXPANDS MARKET REACH IN CHINA
2007.07.31
SINOBIOMED'S MALARIA VACCINE GRANTED AUSTRALIAN PATENT | NEW PATENT PROVIDES PROTECTION IN AUSTRALIA; COMPLEMENTS PATENTS GRANTED IN EUROPE AND U.S.
2007.07.25
SINOBIOMED’S MALARIA VACCINE GRANTED EUROPEAN PATENT | NEW PATENT PROVIDES PROTECTION IN UP TO 37 COUNTRIES IN EUROPE
2007.07.18
SINOBIOMED SUBSIDIARY COMMENCES PRODUCTION OF RECOMBINANT ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
2007.07.10
SINOBIOMED UPDATES ON CLINCIAL TRIAL PROGRESS FOR RECOMBINANT BATROXOBIN (rBAT)
2007.05.29
SINOBIOMED’S INTERNATIONAL PATENT APPLICATION FOR RECOMBINANT BATROXOBIN (rBAT) ACCEPTED | rBAT IS WORLD’S FIRST BATROXOBIN SYNTHESIZED THROUGH GENE RECOMBINATION; NATURAL BATROXOBIN IS WORLD’S MOST PRESCRIBED ANTI-BLEEDING AGENT
2007.05.23
SINOBIOMED SIGNS LETTER OF INTENT TO ACQUIRE PHARMACEUTICAL DISTRIBUTOR | Acquisition Would Give Sinobiomed Control of SFDA GSP Certified pharmaceutical distributor and expand market reach throughout China
2007.05.15
PROF. ZHI-XIN WANG, Ph.D. JOINS SINOBIOMED INC. AS A DIRECTOR
2007.05.09
SINOBIOMED SUBSIDIARY'S PRODUCTION FACILITY RECERTIFIED BY CHINESE STATE FOOD AND DRUG ADMINISTRATION
2007.04.30
DICKEN S. C. KO, MD, FRCSC, FACS JOINS SINOBIOMED, INC. ADVISORY BOARD
2007.04.24
SINOBIOMED’S MALARIA VACCINE GRANTED US PATENT
2007.04.17
SINOBIOMED INC. – CORRECTIVE NEWS RELEASE FOR WEBSITE OF BLUE BLOOD BIOTECH CORP.
2007.04.16
SINOBIOMED INC. SUBSIDIARY SIGNS TECHNICAL COOPERATION AGREEMENT WITH TAIWANESE BIOTECH | Shanghai Wanxing Bio-pharmaceuticals to investigate development of mass production for world’s first recombinant protein to stimulate angiogenesis – the development of new blood vessels
2007.04.11
rhaFGF PRODUCT RECEIVED NEW DRUG CERTIFICATE
2007.03.15
SINOBIOMED - CANCELLATION OF SHARES BY MAJOR STOCKHOLDER
